The South Africa hemodialysis & peritoneal dialysis market size was valued at USD 455.2 million in 2016 and is projected to expand at a CAGR of 7.1% over the forecast period. Rising incidence of kidney failure and chronic renal dysfunction is expected to promote market growth over the forecast period. The Clinical Kidney Journal states that the prevalence of chronic kidney disease in Africa was pegged at 13.9% in 2016.
Increasing the prevalence of hypertension and diabetes is anticipated to drive the need for dialysis as these diseases could result in kidney dysfunction. South Africa has a large patient population with inadequate funding and healthcare facilities that are not too well developed. This provides lucrative growth opportunities to market players in this region. Transplantation and dialysis are the two options available to patients suffering from kidney failure or severe kidney damage. There are very few kidney donors in the region and this situation is unlikely to change in the coming years, thereby propelling the demand for dialysis.
The latest dialysis machines are designed to enhance patient usability through easy setup, treatment, and cleanup. Medtronic launched a new portable dialysis machine in July 2017, which is likely to help patients in remote areas. Advancements such as these are making the procedure simple, less painful, convenient, and time-saving.
On the basis of type, the South Africa hemodialysis & peritoneal dialysis market is segmented into hemodialysis and peritoneal dialysis. As of 2016, hemodialysis dominated the market and is anticipated to retain its dominance through 2025. The segment is poised to exhibit a CAGR of over 7.0% during the forecast period. Hemodialysis is an alternative treatment option for people who failed to receive a kidney transplant. In 2015, the highest number of patients were registered at Gauteng, followed by KwaZulu-Natal and the Western Cape.
Peritoneal dialysis is also expected to witness lucrative growth owing to rising demand for the treatment method amongst neonates and children. Furthermore, the higher applicability of this technique in home-based services is promoting the growth of the segment.
On the basis of product, the market is segmented into devices, consumables, and services. The services segment held the dominant share owing to an increase in the adoption of home-based dialysis and the development of new treatment centers. Africa has few dialysis centers due to a shortage of water supply, poor electricity supply, and the high cost of dialysis machines.
Devices are further segmented into machines, dialyzers, water treatment systems, and others. Dialyzers dominated the market space as of 2016, as it is the primary equipment required for the procedure. Consumables are sub-segmented into bloodlines, concentrates and catheters, and others; concentrates dominated this segment owing to routine and frequent purchase of the product.
On the basis of end use, the market is classified into home-based and hospital-based. Hospital-based dialysis is the largest segment due to the availability of professionals who can address any complications that arise during dialysis and help achieve better results. However, home-based dialysis is anticipated to witness lucrative growth over the forecast period. This can be attributed to a number of factors such as an increase in the development of small and automated products for home use, a rise in the number of individuals requiring daily dialysis, availability of skilled personnel to provide training on self-dialysis, and initiatives by market participants for raising awareness about home dialysis.
Fresenius Medical Care AG & Co. KGaA; B.Braun Avitum AG; NIPRO Medical Corporation; DaVita, Inc.; and Baxter are key players in this region. The market is dominated by a handful of participants, who account for a majority share. They are engaged in growth strategies such as alliances, product differentiation, and diversification, and broadening marketing and distribution channels to increase the reach of their products and gain a competitive edge.
For instance, in July 2016, DaVita announced its support for the Dialysis Patient Demonstration Act. The initiative works to provide better patient care and give power not only to patients and taxpayers but also to physicians, thereby helping in making the healthcare system more efficient.
Report Attribute |
Details |
Market size value in 2020 |
USD 600.3 million |
Revenue forecast in 2025 |
USD 847.2 million |
Growth Rate |
CAGR of 7.1% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2015 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Type, product, end use |
Country scope |
South Africa |
Key companies profiled |
Fresenius Medical Care AG & Co. KGaA; B.Braun Avitum AG; NIPRO Medical Corporation; DaVita, Inc.; Baxter Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the South Africa hemodialysis & peritoneal dialysis market report on the basis of type, product, and end use:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Hemodialysis
Peritoneal dialysis
Product Outlook (Revenue, USD Million, 2014 - 2025)
Devices
Consumables
Services
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Hospital-based
Home-based
b. The global South Africa hemodialysis & peritoneal dialysis market was estimated at USD 561.3 million in 2019 and is expected to reach USD 600.3 million in 2020.
b. The global South Africa hemodialysis & peritoneal dialysis market is expected to grow at a compound annual growth rate of 7.1% from 2017 to 2025 to reach USD 847.2 million by 2025.
b. The South Africa hospital-based segment dominated the market and was valued at USD 450.2 million in 2019. This is attributable to the availability of professionals in hospitals to address any complications that arise during dialysis therapy and due to the availability of reimbursement policies.
b. Some key players operating in the South Africa hemodialysis & peritoneal dialysis market includes Fresenius Medical Care AG & Co. KGaA; B.Braun Avitum AG; NIPRO Medical Corporation; DaVita, Inc.; and Baxter Inc.
b. Key factors that are driving the market growth include rising incidence of kidney failure and chronic renal dysfunction as well as technological advancements.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.